GSK-206924

Study Sponsor: GSK

Study Title

An open-label study to evaluate correct use and ease of use of the ELLIPTA Dry Powder Inhaler (DPI) in pediatric patients currently receiving inhaled therapy for treatment of their asthma

Medicine or Vaccine (generic name)

fluticasone furoate/vilanterol

Sponsor Identification Number

206924

Trial Registry Identification Number(#'s)

NCT03478657

Medical Condition

Asthma

Phase

Phase 4

Link to study details on the GSK Clinical Study Register

https://www.gsk-studyregister.com/en/trial-details/?id=206924

Link to study details on ClinicalTrials.gov (if available)

http://clinicaltrials.gov/show/NCT03478657

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

This study is available in CDISC format.

Date Added to this Site

January 2021